Kelly Federowicz
-
- Acute Myeloid Leukemia Research 1
-
- Protein Tyrosine Phosphatases 2
- CRISPR and Genetic Engineering 1
-
- Cancer-related Molecular Pathways 1
- Cancer Treatment and Pharmacology 1
-
- Autophagy in Disease and Therapy 1
-
- Chronic Lymphocytic Leukemia Research 1
-
- Cancer, Hypoxia, and Metabolism 1
Kelly Federowicz
4 papers receiving 146 citations
Peers
Comparison fields: 5 of 36
- Cell Biology 41
- Hematology 26
- Molecular Biology 120
- Oncology 26
- Epidemiology 22
Countries citing papers authored by Kelly Federowicz
This map shows the geographic impact of Kelly Federowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Federowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Federowicz more than expected).
Fields of papers citing papers by Kelly Federowicz
This network shows the impact of papers produced by Kelly Federowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Federowicz. The network helps show where Kelly Federowicz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kelly Federowicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 12 | |
| 3 | 2018 | 49 | |
| 4 | 2017 | 43 | |
| 5 | 2015 | 42 |
About Kelly Federowicz
Kelly Federowicz is a scholar working on Genetics, Hematology and Oncology, having authored 5 papers that have together received 146 indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (2 papers), Autophagy in Disease and Therapy (1 paper), Cancer-related Molecular Pathways (1 paper), Acute Myeloid Leukemia Research (1 paper), CRISPR and Genetic Engineering (1 paper), Chronic Lymphocytic Leukemia Research (1 paper), Cancer Treatment and Pharmacology (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Cell Biology (41 citations), Hematology (26 citations) and Molecular Biology (120 citations). Kelly Federowicz has collaborated with scholars based in United States, Belgium and Netherlands. Frequent co-authors include Dirk A. Heerding, Jingsong Yang, Andreas Ernst, Satra Nim, Yufeng Tong, Aiping Dong, Jason Moffat, Taras Makhnevych, Wei Zhang and Dania Haddad. Their work appears in journals such as Journal of Molecular Biology, Biochemistry and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.